Skip to main content

Site notifications

Note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder

We have adopted this International Scientific Guideline - CPMP/EWP/567/98 

Last updated

Help us improve the Therapeutic Goods Administration site